Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.
Element 25 has obtained key regulatory approval from WA's DEMIRS for its Butcherbird Expansion Project, paving the way for a twelve-year production run at 1.1 million tonnes per annum of manganese concentrate. The final hurdle remains the Works Approval, expected imminently.
